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As of April 1, 2009, the Iowa VFC 
Program expanded Hepatitis A vaccine 
coverage of VFC eligible children to 
include children 1 through 18 years of 
age.  Previously, the program had only 
provided Hepatitis A vaccine for children 
12-23 months of age.   
Recalling patients for mass Hepatitis A 
vaccination clinics is not necessary, 
however clinics should review patient 
immunization histories at future visits 
and provide Hepatitis A vaccine as 
indicated.   
A chart that outlines what vaccines are 
covered by the Iowa VFC Program and 
at what ages is available on our Web 
page:  
www.idph.state.ia.us/adper/common/pd
f/immunization/vfc_vaccine_covered_ag
e_ranges.pdf 
 For questions regarding Hepatitis A 
vaccine contact Terri Thornton at 800-
831-6293, ext. 2 or Bridget Konz at ext. 
7.  For Hepatitis A vaccine ordering 
questions, contact Janean Iddings at 
ext. 5. 
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With spring storms on the horizon,   
the Immunization Program urges 
clinics to review their Vaccine 
Storage and Handling Plan and 
Vaccine Emergency Response Plan.  
A template for these documents are 
found on our Web page: 
http://www.idph.state.ia.us/adper/co
mmon/pdf/immunization/storage_ha
ndling_guide.pdf.   
Review of the plans should include 
contacting their back-up storage 
facility to ensure they remain 
capable of properly storing vaccine 
should an emergency move be 
necessary, as well as review 
transport procedures.   
Remember that Varicella 
containing products must be 
moved on dry ice, even if the 
distance is short.   
Varicella containing vaccine (Varivax and 
Zostavax) that is moved on regular ice 
will not be viable and must not be 
administered.  
Clinics are reminded that if temperatures 
in their storage units deviate from the 
normal ranges of 35°- 46°F in the 
refrigerator and less than 5°F in the 
freezer that immediate action must 
be taken.   
The manufacturers must be contacted for 
instructions and the Immunization 
Program must be notified and informed 
of action taken to safeguard the vaccine 
supply.   
For information on vaccine storage and 
handling, contact Terri Thornton at 800-
831-6293, ext. 2.  
unization Program
April Showers Bring...Vaccine  S & H Incidents? 
2 
As we enter spring, kindergarten 
round-ups and school physicals are 
in full swing.  The Immunization 
Program would like to remind 
school nurses and providers of the 
changes to Iowa’s Immunization 
law and that we have free 
education materials available to 
assist with informing parents about 
their role in immunizations and 
documentation for school.    
For the 2009-2010 school year, 
children entering kindergarten are 
required to have additional doses 
of DTaP, Polio, and Varicella.  The 
new requirements include the 
following doses: 5 DTaP, 4 Polio, 
Law.  The brochure “Iowa 
Immunization Law and You” 
outlines the immunization certificate 
requirements and has an easy to 
interpret immunization requirement 
chart.  This brochure is available in 
English and Spanish through the 
Health Protection Clearinghouse.   
To order free brochures go to the 
Immunization Program Web page 
(http://www.idph.state.ia.us/adper/i
mmunization.asp) and click on the 
green button labeled “Immunization 
Print Materials.”  For questions 
contact Bridget Konz at 800-831-
6293, ext. 7.    
and 2 Varicella vaccinations. Children 
must also have 2 doses of MMR and 
3 doses of  Hepatitis B vaccine.  
Please be aware there are age and 
dose caveats to these requirements. 
The Immunization Program has 
consolidated the requirements for 
licensed child care and school entry 
into a easy-to-use one page 
document which is available at: 
http://www.idph.state.ia.us/adper/co
mmon/pdf/immunization/immunizati
on_requirements.pdf 
Additionally, we have free education 
resources available for schools and 
child care facilities to educate 
parents on Iowa’s Immunization  
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Do you need free, quality immunization information  
for your clinic, hospital, school, or health department?    
The Iowa Department of Public Health contracts with 
the Cedar Rapids Library and the Health Protection 
Clearinghouse to bring you “one-stop shopping” for 
your immunization education supplies.   
The Immunization Program offers brochures, both 
English and Spanish, for on a variety of topics as well 
as Vaccine Information Statements and VFC program 
documents.  
All of our information is offered free of charge.  To 
preview items available from the Immunization 
Program go to our Web page 
http://www.idph.state.ia.us/adper/immunization.asp 
and click on the green button titled “Immunization 
Print Materials.”  On this page you will be able to 
preview all the items we offer, print single copies if 
needed, and order large qualities of materials.   
Some items do have quantity limits on them, however 
if you need more than the allowable amount, please 
contact Bridget Konz at 800-831-6293, ext.7.   
Free Immunization             
Education Materials 
Kindergarten Round Up Time! 
Immunization Update 2009 
 
Mark your calendars for the July 30, 2009, Live 
Satellite Broadcast and Web cast from CDC’s National 
Center for Immunization and Respiratory Diseases 
(NCIRD).  
The event will take place from 9:00 AM – 11:30 AM 
and 12:00 – 2:30 PM EST. More information about 
this broadcast will soon be available at the 
http://www.cdc.gov/vaccines/ed/default.htm 
National Infant Immunization Week (NIIW) will be 
celebrated April 25-May 2, 2009, in conjunction with 
Vaccination Week in the Americas (VWA). The theme 
for NIIW is "Love them. Protect them. Immunize 
Them." Visit the NIIW Events Web page 
(http://www.cdc.gov/vaccines/events/niiw) for 
planning and evaluation resources, public relations 
materials, and communication campaign materials. 
Add your local activity to the National Calendar of 
NIIW Events   
http://www.cdc.gov/vaccines/events/niiw/2009/09acti
vities.htm.  
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The national vaccine supply continues to 
experience a shortage of haemophilus 
influenzae B vaccine (Hib) PedvaxHIB 
manufactured by Merck.  
As a result, the IDPH Immunization 
Program continues to review and fill 
limited orders with ActHIB or Hib-
containing Pentacel both manufactured by 
sanofi pasteur.   
Recent cases of invasive Hib disease in the 
United States highlight the importance of 
giving the 2 or 3 dose primary Hib series 
(ActHIB = 3 dose primary series, 
PedvaxHIB = 2 dose primary series) to 
children.  
Due to the on-going Hib shortage, 
providers should continue to defer the 
booster dose of Hib-containing vaccine at 
the 12-15 month visit.  Additionally, it is 
critical to keep up-to-date documentation 
of children who are deferred so that recall 
reminders can be made once the shortage 
is over.   
The Iowa Department of Public Health has 
extended the “Hib Waiver” that allows 
children to attend a licensed child care 
center without the booster dose of Hib 
from December 31, 2008, to September 
30, 2009. It is anticipated the Hib 
shortage will be resolved prior to 
September. Copies of the Hib Waiver are 
available at: 
http://www.idph.state.ia.us/adper/commo
n/pdf/immunization/hib_waiver.pdf 
If you have questions regarding vaccine 
availability contact Janean Iddings at 1-
800-831-6293, ext. 5, or for vaccine 
questions please contact Terri Thornton or 
Bridget Konz at 1-800-831-6293, ext. 2 
and 7 respectively.  
Review of HIB Recommendations:  
 
The following non-high risk children should be scheduled to  
receive the primary series of Hib vaccine as outlined below:    
 If the child is at least 6 weeks but less than 12 months of 
age and has received zero, one, or two doses of Hib 
vaccine, schedule him/her for the first or next dose(s) 
immediately with a minimum of four weeks between the 
doses. These children will need one booster dose when the 
Hib vaccine shortage is over. 
 If the child is between 12 and 14 months of age and has 
not had any doses of Hib vaccine, schedule appointments 
for two doses, eight weeks apart.   
 If the child is between 12 and 14 months of age and has 
received Hib vaccine but did not complete the primary series 
before they turned 1-year-old (i.e., had 1 dose of the Merck 
product OR 1-2 doses of the sanofi product), schedule an 
appointment for 1 additional dose, a minimum of eight 
weeks from the last dose. 
 If the child is at least 15 months of age but less than 5 
years of age and has not received any doses of Hib vaccine 
OR has not completed the primary series (i.e., had 1 dose of 
the Merck product OR 1-2 doses of the sanofi product), 
schedule an appointment for one dose. 
 If the child is 5 years old or older and hasn't received any 
Hib vaccine, Hib vaccine is not necessary. 
 
Certain children are at increased risk for Hib disease, including children 
with asplenia, sickle cell disease, human immunodeficiency virus 
infection, and certain other immunodeficiency syndromes, and 
malignant neoplasms.  CDC recommends that providers continue to 
vaccinate these children with available Hib conjugate vaccines 
according to the routinely recommended schedules, including the 12-
through-15-month booster dose.  
 
Providers who serve predominantly American Indian/Alaska Native 
(AI/AN) children living in AI/AN communities should continue to stock 
and use PRP-OMP–containing Hib vaccines (Merck product) and 
vaccinate according to the routinely recommended schedule, which 
includes the 2-dose primary series (ages 2 and 4 months) and a 12-
through-15-month booster dose.   
For more information contact the Iowa Immunization Program at 800-
831-6293.  
HIB Shortage Continues... 
Need Information? Check Out a New Interactive Tool from CDC.  
CDC has developed a Sortable Table of Standardized Vaccine Abbreviations. This 
tool will enable users to quickly sort by vaccine name, abbreviation, trade name, or 
manufacturer and can be found at 
http://www.cdc.gov/vaccines/about/terms/USVaccines.html 
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Modernization Act will benefit 
Iowans in ways that are already 
being recognized by more than 20 
other states. Like Iowa’s 
Modernization initiative, their goal is 
voluntary accreditation of public 
health agencies.  
As public health agencies in our 
state become accredited, Iowans 
will begin to see a number of 
benefits. These include increased 
and improved public health service 
delivery accompanied by a system of 
quality improvement and 
accountability.  
Modernization also means increased 
capacity for public health to respond 
to disease outbreaks, natural 
disasters, and other events that 
threaten the health of Iowans. This 
effort will create a nimble system 
that can respond to public health 
threats as well as provide the basic 
population-based services Iowans 
have come to expect. 
IDPH is requesting state funding as 
well as seeking funding from other 
entities in order to support pilot 
projects related to Modernization 
efforts, create efficiencies in public 
health, and help address gaps in 
infrastructure.  
For more information about 
Modernizing Public Health in Iowa, 
including FAQs, fact sheets, 
information about projects in other 
states, and more, visit 
www.idph.state.ia.us/mphi.  
You may also contact Joy Harris at 
515-281-3377 or 
JHarris@idph.state.ia.us. 
 
  
Providers may have heard about 
Iowa’s recent efforts to 
modernize its public health 
system. But what does this have 
to do with immunization 
services? A lot, according to 
Iowa Department of Public 
Health (IDPH) Director Tom 
Newton. 
“As partners in public health, 
immunization providers hold 
themselves to a high standard of 
excellence,” Newton said. 
“Unfortunately, those standards 
and many others in public health 
have yet to be formalized. This 
has to change.” 
The “standards” Newton cites 
are the Iowa Public Health 
Standards, developed as a part 
of the Redesigning Public Health 
in Iowa initiative. The purpose of 
the standards is to describe the 
basic services and infrastructure 
that all Iowans can reasonably 
expect from local and state 
public health.  
Work on the standards began in 
2004 and now forms the 
backbone of the current 
Modernizing Public Health in 
Iowa initiative. The Iowa 
legislature is currently 
considering adopting standards 
for public health through 
legislation called the Public 
Health Modernization Act.  
For Iowa’s immunization 
providers, this legislation means 
that the people they serve will 
have access to the same public 
health services no matter where 
they live in Iowa. In a broader 
sense, passage of the  
The Merck Patient Assistance 
Program is a private and confidential 
program that provides medicine free 
of charge to eligible individuals, 
primarily the uninsured who, without 
assistance, could not afford needed 
Merck medicines.  
Effective March 1, 2009, the Merck 
Patient Assistance Program increased 
the income eligibility requirement for 
the program, thereby allowing more 
people in need to receive Merck 
medicines for free.   Patients may 
now be eligible for the Merck Patient 
Assistance Program if their household 
income is $43,320 or less for 
individuals, $58,280 or less for 
couples, or $88,200 or less for a 
family of four (previous income limits 
were $21,660, $29,140 and $44,100 
respectively).   
You can download copies of the 
Merck Patient Assistance Program 
application at www.merckhelps.com.   
For more information on the Merck 
Patient Assistance Program,  visit 
www.merckhelps.com or call 1-800-
727-5400. 
Merck Patient            
Assistance Program  
Registration Now 
Open! 
The Iowa Statewide 
Immunization Conference will 
be held in Downtown Des 
Moines at the Hy-Vee Hall on  
June 11, 2009  
There will also be a lecture and 
reception the evening of June 10th.  
For more details and to register 
online, go to  
 
www.trainingresources.org/ViewConf
.aspx?id=1355 
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What Is VAERS    
The Vaccine Adverse Event Reporting 
System (VAERS) is a national program 
that monitors the safety of vaccines 
after they are licensed.  VAERS is 
managed by the U.S. Centers for 
Disease Control and Prevention (CDC) 
and the U.S. Food and Drug 
Administration (FDA).  
Vaccines prevent serious illnesses and 
even death in persons who receive 
them.  Before a vaccine is licensed,  
FDA takes steps to make sure the 
vaccine is safe.  FDA requires that a 
vaccine goes through extensive safety 
testing.  After a vaccine is licensed, 
VAERS is one of the mechanisms used 
to monitor for any problems, or 
“adverse events,” that happen after 
vaccination.  
Not all events reported to VAERS are 
caused by the vaccine.  Even though 
careful studies are done before a 
vaccine is licensed, rare adverse 
events may not be found until a 
vaccine is given to millions of people 
with different backgrounds and 
medical histories.  By continued 
monitoring, VAERS helps to make sure 
that the benefits of vaccines are far 
greater than the risks. 
Anyone who receives a vaccine should 
be informed about both the benefits 
and risks of vaccination.  Any 
questions or concerns should be 
discussed with a healthcare provider.  
Limitations and 
Usefulness of VAERS    
VAERS is unable to determine that a 
vaccine caused or did not cause an 
adverse event.   
APRIL 2009 IMMUNIZATION UPDATE:  I A I MUNIZATION PROGRAM N WSLETTER 
Vaccine Adverse Event Reporting System (VAERS) 
Sometimes people who are vaccinated 
get sick from another cause unrelated to 
the vaccine.  
Even though VAERS cannot determine 
that a vaccine caused an adverse event, 
it can give FDA and CDC important 
information that might signal a problem.  
If it looks as though a vaccine might be 
causing an adverse event, FDA and CDC 
will investigate further.  
Does VAERS Provide 
Medical Advise?     
No, VAERS does not provide medical 
advise.  For medical advice should be 
provided by the healthcare provider. 
 
 
 
 
 
Who Can Report to VAERS? 
 Parents 
 Patients 
 Healthcare Providers 
 Others      
FDA and CDC encourage anybody who 
experiences a problem after vaccination 
to report to VAERS.  Healthcare providers 
are required by law to report certain 
problems.  The National Childhood 
Vaccine Injury Act (NCVIA) requires 
health care providers to report: 
 Any event listed by the vaccine 
manufacturer as a contraindication 
to subsequent doses of the vaccine. 
 Any event listed in the Reportable 
Events Table that occurs within the 
specified time period after 
vaccination.  
 
 
A copy of the Reportable Events Table can 
be found in the CDC Pink Book or 
obtained by calling VAERS at 1-800-822-
7967 or by downloading it from 
http://vaers.hhs.gov/pubs.htm. 
Why Should I Report to 
VAERS? 
 Reporting gives valuable information 
that helps CDC and FDA make sure 
that vaccines are safe. 
 Reporting strengthens VAERS so it 
can be used to assess public health 
response to vaccines.  
 Reporting allows for evaluating public 
health prevention and control 
measures.  
Remember, no vaccine (or any medicine) 
is completely free of risk and adverse 
events are possible.  If you have an 
adverse event after a vaccine, please 
report to VAERS—each report is 
important! 
VAERS forms can be ordered by calling 1-
800-822-7967, or download a printable 
copy of the VAERS form from the 
following Internet sites 
http://vaers.hhs.gov/ 
www.fda.gov/cber/vaers/vaers.htm or 
www.cdc.gov/vaccines/ 
For more information: Send e-mail 
inquiries to info@vaers.org  or visit the 
VAERS Web site at: http://vaers.hhs.gov   
Call the toll-free VAERS information line at 
(800) 822-7967. Fax inquiries to the toll-
free information fax line at (877) 721-
0366.   
For information regarding VAERS at the 
Iowa Immunization Program, contact Terri 
Thornton at 1-800-831-6293, ext 2. 
